Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
The DOJ’s updated compliance guidelines require proactive AI risk management. Take steps to ensure your company meets the standards.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
Explore how proposed Medicaid cuts could impact health care valuations, reimbursement models and financial stability across various provider segments.
PodcastExplore key trends in government health care, from funding challenges to innovation, and how policies will shape the future of patient care.
Within the changing landscape of educational technology, schools face new risk factors that affect students, faculty and administrators.
Learn how financial institutions can manage third-party risks, protect customer trust and minimize disruptions from critical service outages.
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Explore year-end considerations including the critical aspects of 45Z credits, ITC for biogas and strategies for clean fuel production credits.
Shale maturation and technological innovation impact IP valuations, influencing long-term asset value and productivity in the oil and gas industry.
Companies looking to transform their operations through AI will need to guard against risk from vendors without a SOC 2 report. Learn more here.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
